Gebruikersprofielen voor M. Egger

Matthias Egger

Professor of Epidemiology & Public Health, University of Bern
Geverifieerd e-mailadres voor ispm.unibe.ch
Geciteerd door 557383

A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints

RM Harbord, M Egger, JAC Sterne - Statistics in medicine, 2006 - Wiley Online Library
… rate than the linear regression test proposed by Egger et al. [7], though at … Egger et al. [7]
and by Macaskill et al. [14], while Section 4 introduces our proposed modification of the Egger

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

AG Renehan, M Tyson, M Egger, RF Heller, M Zwahlen - The lancet, 2008 - thelancet.com
Background Excess bodyweight, expressed as increased body-mass index (BMI), is
associated with the risk of some common adult cancers. We did a systematic review and meta-…

Grey literature in meta‐analyses of randomized trials of health care interventions

…, S McDonald, MJ Clarke, M Egger - Cochrane Database of …, 2007 - cochranelibrary.com
… This review builds on work carried out by one of the authors (Egger 2003) and systematically
reviews research studies that have investigated the impact of including grey literature in …

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally …

…, UM Martens, P Thuss-Patience, M Egger… - The Lancet, 2019 - thelancet.com
Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal
junction adenocarcinoma. This study reports on the safety and efficacy of the …

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

…, E Balestre, JA Sterne, M May, M Egger - Lancet (London …, 2006 - europepmc.org
Background Highly active antiretroviral therapy (HAART) is being scaled up in developing
countries. We compared baseline characteristics and outcomes during the first year of HAART …

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in …

…, S Probst, M Koenigsmann, M Egger… - The lancet …, 2016 - thelancet.com
… /m 2 on day 1, intravenous cisplatin 60 mg/m 2 on day 1, and either fluorouracil 200 mg/m 2
… infusion or capecitabine 1250 mg/m 2 orally (two doses of 625 mg/m 2 per day) on days 1 to …

Predatory journals: no definition, no defence

…, M Berger, JB Ciro, L Cugusi, MR Donaldson, M Egger… - Nature, 2019 - nature.com
Leading scholars and publishers from ten countries have agreed a definition of predatory
publishing that can protect scholarship. It took 12 hours of discussion, 18 questions and 3 …

[HTML][HTML] Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster …

…, M Egger, MW Carroll, NE Dean, I Diatta, M Doumbia… - The Lancet, 2017 - thelancet.com
Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based
candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

…, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay… - The Lancet, 1999 - thelancet.com
… B Ledergerber and M Egger conceived the study and did the statistical analyses. All authors
contributed to the text of the first draft of the manuscript. M Egger, B Ledergerber, and R …

Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement

…, V Gallo, A Tybjaerg-Hansen, GD Smith, M Egger… - Jama, 2021 - jamanetwork.com
Importance Mendelian randomization (MR) studies use genetic variation associated with
modifiable exposures to assess their possible causal relationship with outcomes and aim to …